Jason O'Byrne, EVP & Chief Financial Officer at Vir Biotechnology, Inc. (VIR), sold 6,799 shares at $5.56 ($38K) on 2025-11-17, disclosed to the SEC on 2025-11-18.
Open-market sale of $38k VIR by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |